In summary, we immunolocalized CCL5 and CCR1, 3 and 5 in breast carcinoma tissues and demonstrated that the expression of CCL5 in stromal cells was significantly correlated with tumor progression in a paracrine manner via CCR3 expressed in breast carcinoma cells (Figure 3). The gene discussed is CCL5; the disease is neoplasm.